The CAPN5 gene gives your cells instructions for making a protein that helps control how other proteins are processed, especially in the retina, the light sensing tissue at the back of the eye. This gene plays an important role in keeping retinal cells balanced. When its activity is disrupted by a harmful variant, it can cause a rare inherited eye condition with inflammation, scarring, and gradual vision loss. Most people hear about the CAPN5 gene only when doctors investigate retinal disease that runs in families.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate activities in the body. Some genes hold the directions for producing proteins, which do much of the cell’s work. Other genes mainly control when certain processes happen, where they take place, and how active they are. Together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. For a deeper look at this topic, you can find more in LearnHub.
Overview
CAPN5Gene function
What if the gene works
The CAPN5 gene helps make calpain-5, an enzyme that cuts other proteins in a controlled way. It is active in the retina and other tissues, where it supports normal cell signaling and maintenance.
Risk
What if the gene does not work
Variants in the CAPN5 gene can cause an eye condition with inflammation, retinal damage, and worsening vision. Milder or more severe variants may affect when symptoms begin and how much vision is affected. Rare severe variants may also affect hearing.
Treatment
What does that mean for your treatment
No CAPN5-specific treatment or drug choice is currently established. In rare eye disease linked to pathogenic variants in the CAPN5 gene, care is still guided by the eye findings themselves, while CAPN5 is being studied as a possible drug target.
Conditions associated with CAPN5
Gene function
What if the gene works
Inside many cells, the CAPN5 gene helps fine tune how proteins behave from moment to moment. It gives instructions for calpain-5, a calcium-activated protein-cutting enzyme that trims selected proteins rather than breaking them down completely. This careful trimming helps cells adjust everyday tasks in a controlled way.
The CAPN5 gene helps cells make small, targeted cuts in certain proteins. These trims can switch a protein on, tone it down, or change where it works inside the cell.
Calpain-5 becomes active when calcium levels rise inside a cell. This is part of how the CAPN5 gene helps cells respond to calcium during normal cell signaling.
By adjusting selected proteins, the CAPN5 gene supports routine signaling inside cells. This helps cells make measured changes in activity instead of broad, all at once shifts.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and the way the body responds to environmental factors. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can more substantially change how a gene functions and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
How CAPN5 gene variants affect protein function depends on how much they change the enzyme's shape and calcium control. Many disease linked variants are missense changes that make the CAPN5 protein too active, so it cuts other proteins at the wrong time and can injure retinal cells. Some changes may cause a milder increase in activity, while stronger variants often lead to earlier and more severe inherited eye disease.
How variants are linked to conditions
The clearest CAPN5 gene condition association is autosomal dominant neovascular inflammatory vitreoretinopathy, a rare inherited eye condition. Pathogenic variants can cause progressive eye inflammation, retinal damage, and vision loss. A disease-causing variant in the CAPN5 gene can help confirm this diagnosis, while other reported links are much less established.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widespread in the general population. Most do not have a direct effect on health and instead represent normal human variation. For many genes, carrying a variant associated with a condition suggests a possible link rather than a certain diagnosis, especially when multiple genes and environmental factors contribute. In some situations, however, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For harmful changes in the CAPN5 gene, the main factor is whether the variant was inherited in the family, and risk is largely set by that genetic change. There is not enough evidence to say that lifestyle or environmental factors clearly raise or lower the chance of developing CAPN5-related eye disease, but regular eye follow-up can help find changes early.
Inheritance of CAPN5 variants
CAPN5-related eye disease is usually inherited in an autosomal dominant pattern, which means one altered copy of the CAPN5 gene can be enough to pass the condition from a parent to a child. In families with this pattern, each child has a 50% chance of inheriting the variant. This overview of the inheritance of CAPN5 gene variants applies to the well-established retinal condition linked to CAPN5. Men and women can inherit and pass on the variant equally.
What does my CAPN5 result mean for my family?
For CAPN5, the best-known inherited condition follows a dominant pattern, which means close relatives such as a parent, brother, sister, or child may also carry the same change. In many families, each child of someone with a disease-causing CAPN5 variant has a 1 in 2, or 50%, chance of inheriting it. Because of that, family members may also want to discuss whether testing could be helpful, especially if there is a history of eye disease in the family.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for CAPN5 variants uses a blood or saliva sample, which a lab analyzes to look for changes in the CAPN5 gene. Results may find a known variant, find no relevant variant, or show a variant of uncertain significance, which means its health effect is still unclear.
When should I consider getting a genetic test?
Consider CAPN5 genetic testing if you or close relatives have a rare inherited eye condition with repeated eye inflammation and gradual vision loss, especially across several generations. A CAPN5 result can help confirm the cause and clarify whether other family members may also carry it.
A genetic result is only one part of your health story
Genetic test results can provide useful insight, but how much they reveal varies with the condition and the kind of variant found. Factors including lifestyle, environment, age, and medical history also shape how the body functions over time. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and makes the most sense when considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help place personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, how strongly a drug reaches its target, or how sensitive someone is to side effects. This helps explain why the same medication works well for one person but less well for another. These differences are common and can influence both how effective a treatment feels and how the body handles it.
What is Pharmacogenetics?
Pharmacogenetics examines the ways genetic differences can affect how someone responds to medicine. It studies links between genes and medications to explain why the same treatment may not work the same way for everyone. With many drugs, genes can influence both how the medicine is handled by the body and how strong its effects are. This information can support more informed, personalized treatment choices. More detail on this topic is available in the LearnHub.
Drugs influenced by the CAPN5 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work or which side effects may happen. For any concerns about symptoms, treatment choices, or how you respond to a medicine, talk with your doctor or pharmacist.
History
CAPN5 entered the medical literature through families with a rare inherited eye condition called autosomal dominant neovascular inflammatory vitreoretinopathy, or ADNIV. In recent decades, awareness of this gene’s role has grown as researchers traced the condition through several generations and then identified CAPN5 as the shared cause. That finding helped explain a long-standing clinical puzzle in people who developed inflammation, retinal damage, and vision loss running in families. Building on this early work, scientists uncovered more about the range of CAPN5 variants linked to inherited eye disease. The way this gene was viewed has shifted over time, from a little known member of a larger gene family to a recognized cause of a specific retinal condition.